$SLRC

SLR Investment Corp. (NASDAQ:SLRC) Given Consensus Recommendation of "Hold" by Brokerages

SLR Investment Corp. (NASDAQ:SLRC) has received a consensus "Hold" recommendation from eight brokerages, with an average 12-month price target of $15.29. The company offers a quarterly dividend of $0.41, equating to an annualized yield of 10.4%, and insiders own 8.8% of the stock. Recent analyst activities include upgrades from "neutral" to "buy" by Compass Point, and a decrease in price objective by Wells Fargo & Company.

Original reporting
MarketBeat · MarketBeat
Published Apr 15, 2026, 8:44 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Apr 15, 2026, 9:30 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
SLR Investment Corp. (NASDAQ:SLRC) Given Consensus Recommendation of "Hold" by Brokerages — source image
Decision brief

The 30-second read

$SLRCNeutralLow
01

Why it matters

The neutral analyst consensus and dividend stability suggest limited immediate impact on stock price, but long-term income investors may find it attractive.

02

Market read

The news is relevant primarily to income-focused investors and those monitoring the financial sector's stability.

03

What to watch

Potential upcoming changes in interest rates or sector-specific regulations could impact future performance beyond current analyst ratings.

Relevance 6/10Timing: long-term

Background

SLR Investment Corp. is a business development company providing debt and equity financing to middle-market companies.

Company-level read

Ticker impact

$SLRCNeutralMedium confidence
Context

The news pertains directly to SLR Investment Corp. (NASDAQ:SLRC), providing relevant analyst opinions and valuation metrics.

Expected impact

Minimal short-term price movement expected; potential for sideways trading within current support and resistance levels.

Evidence & confidence

The consensus recommendation and recent analyst activities indicate stability but lack strong bullish or bearish signals. Technical indicators are not provided, limiting precise short-term predictions.

$SLRCNeutralMedium confidence
Context

The news is directly about SLRC, affecting its trading decisions.

Expected impact

Likely range-bound trading with slight fluctuations; no significant directional move anticipated.

Evidence & confidence

The lack of strong buy or sell signals and the stable dividend suggest limited price volatility in the near term.

Market effects

The financial sector, particularly investment management firms, may experience stable sentiment due to dividend yields and analyst ratings.

Limited regional impact; primarily relevant to U.S. investors and market conditions.

Negligible; the news is specific to a U.S.-listed investment company.

Counterpoint

Some investors may interpret the 'Hold' recommendation as a sign to wait for clearer bullish signals before investing.

Key entities

  • SLR Investment Corp.

    A business development company focusing on middle-market investments.

  • Analyst Firms (e.g., Compass Point, Wells Fargo & Company)

    Institutions providing analyst ratings and price targets.

Related articles

$SLRCHigh

SLR Investment Corp. Announces Quarter Ended September 30, 2026 Financial Results

SLR Investment Corp. (SLRC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 SLR Investment Corp. Announces Quarter Ended September 30, 2026 Financial Results Net Investment Income of $0.33 Per Share for Q3 2026; Declared Quarterly Distribution of $0.31 Per Share NEW YORK, Nov. 03, 2026 (GLOBE NEWSWIRE) -- SLR Investment Corp. (NASDAQ: SLRC)

$SLRCMed

SLR Investment Corp. Announces Quarter Ended June 30, 2026 Financial Results

SLR Investment Corp. (SLRC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 SLR Investment Corp. Announces Quarter Ended June 30, 2026 Financial Results Net Investment Income of $0.33 Per Share for Q2 2026; Declared Quarterly Distribution of $0.31 Per Share NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- SLR Investment Corp. (NASDAQ: SLRC) (the

$ZYMEMedAI 8/10

Zymeworks (ZYME) Gains Fresh Backing On Trial Data And Roche Deal

Zymeworks (ZYME) gained attention due to Phase 1 trial data for ZW191 in ovarian cancer and a licensing deal with Roche for ZW209. The stock has seen significant returns: 19.8% in 1 month, 28.2% in 3 months, 65.9% in 1 year, and 4x in 3 years. Analysts debate its valuation, with some seeing it as 27% undervalued at a fair value of $41.50, while others note its high P/B ratio of 26.6x compared to peers.

$NICEMed

NICE cuts 500 jobs as AI reshapes customer-service business

NICE, a customer-service software company, is cutting 5% of its workforce (500 jobs) to adapt to AI-driven changes. It plans to sell its Actimize business, invest in AI, and acquire a German AI startup for $1B. NICE's stock has declined, and revenue is projected to exceed $3B, but earnings may face pressure.

$DORMMed

Dorman Products Eyes Growth in Electronics, Specialty Vehicles and Aftermarket Exclusives

Dorman Products (DORM) sees growth in electronics, specialty vehicles, and aftermarket exclusives. The company expects a large repair-opportunity funnel in North America, driven by high-dollar vehicle failures. Dorman plans to expand in heavy-duty vehicles and consolidate the fragmented specialty vehicle market. CFO Charles Rayfield anticipates a 40% gross margin by Q4, with capital allocation focused on debt maintenance, product development, M&A, and share repurchases.